Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATAIR: Omalizumab in Non-atopic Asthma
NCT01007149Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of omalizumab in nonatopic asthma, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
nonatopic asthma
Beyond the preview
Go deeper on NCT01007149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007149.